PI-LAB-2026-097

BPC-157, Independent Lab Report

BPC-157 10mg · Sterling Compound Co.

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 97.6% met the stated ≥99% claim. Content measured 97.7% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
97.6%

Label claimed ≥99%

Content accuracy
97.7%

9.77mg measured against 10mg claimed

Test recency
Current cycle

Published 3 months ago

Specimen PI-LAB-2026-097 Tested by Chelsea Analytical Group 14 samples tested from this company Purity & Testing score 91/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 99% 97.6% Within analytical tolerance
Identity (MS) BPC-157 Confirmed Matches label
Content 10 mg 9.77 mg Within 5% of label

Methodology & chain of custody

RP-HPLC purity with electrospray ionisation mass confirmation.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Chelsea Analytical Group. See our full testing methodology.

Lot / batch
L6214-26
Purchased
Analysed
Published
Laboratory
Chelsea Analytical Group
Test type
Full panel (purity, identity, content, endotoxin)

Original laboratory report: PI-LAB-2026-097-report.pdf (document delivery arrives with the production storage backend)

More Tests, Sterling Compound Co.

TB-500
Purity 97.6% Verified
Tirzepatide
Purity 98.7% Verified
GHRP-2
Purity 97.0% Verified

More Tests, BPC-157

BPC-157 Research Peptides Co.
Purity 98.7% Verified
BPC-157 Quantum Peptide Group
Purity 97.1% Verified
BPC-157 Apex Peptides
Purity 94.9% Verified